Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA.

	Organisation	Seres Therapeutics Inc. (Nasdaq: MCRB)
	Organisation 2	Nestlé Health Science S.A.
	Group	Nestlé (Group)
	Person	Pomerantz, Roger (Flagship Ventures 2014– + Seres Therapeutics 201406–CEO before Merck (US))

Original document
accessed by [iito] on 2019-03-13

Record changed: 2023-06-05

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Seres Therapeutics Inc. (Nasdaq: MCRB)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)